Bracebridge Capital LLC’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Hold |
459,216
| – | – | 0.08% | 16 |
|
|
2025
Q1 | $1.33M | Hold |
459,216
| – | – | 0.09% | 14 |
|
|
2024
Q4 | $1.63M | Buy |
459,216
+30,645
| +7% | +$109K | 0.12% | 18 |
|
|
2024
Q3 | $2.13M | Hold |
428,571
| – | – | 0.35% | 13 |
|
|
2024
Q2 | $1.11M | Hold |
428,571
| – | – | 0.2% | 9 |
|
|
2024
Q1 | $1.83M | Hold |
428,571
| – | – | 0.23% | 10 |
|
|
2023
Q4 | $866K | Hold |
428,571
| – | – | 0.19% | 8 |
|
|
2023
Q3 | $656K | Hold |
428,571
| – | – | 0.1% | 9 |
|
|
2023
Q2 | $707K | Hold |
428,571
| – | – | 0.39% | 16 |
|
|
2023
Q1 | $489K | Hold |
428,571
| – | – | 0.13% | 36 |
|
|
2022
Q4 | $387K | Hold |
428,571
| – | – | 0.04% | 61 |
|
|
2022
Q3 | $501K | Hold |
428,571
| – | – | 0.09% | 73 |
|
|
2022
Q2 | $274K | Hold |
428,571
| – | – | 0.04% | 78 |
|
|
2022
Q1 | $1.12M | Hold |
428,571
| – | – | 0.08% | 59 |
|
|
2021
Q4 | $1.67M | Hold |
428,571
| – | – | 0.1% | 50 |
|
|
2021
Q3 | $1.87M | Hold |
428,571
| – | – | 0.17% | 44 |
|
|
2021
Q2 | $1.7M | Hold |
428,571
| – | – | 0.15% | 41 |
|
|
2021
Q1 | $2.23M | Hold |
428,571
| – | – | 0.19% | 24 |
|
|
2020
Q4 | $2.29M | Hold |
428,571
| – | – | 0.35% | 9 |
|
|
2020
Q3 | $2.08M | Hold |
428,571
| – | – | 0.33% | 8 |
|
|
2020
Q2 | $2.08M | Hold |
428,571
| – | – | 0.61% | 8 |
|
|
2020
Q1 | $1M | Hold |
428,571
| – | – | 0.18% | 9 |
|
|
2019
Q4 | $2M | Buy |
+428,571
| New | +$2M | 0.16% | 10 |
|